Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine vs NPH in children with type 1 diabetes mellitus
CTR20140079Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in diabetes mellitus type 1 (T1D), sponsored by Sanofi. Started May 2014; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on CTR20140079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140079.